Effect of vitamin C on endothelial function in health and disease: a systematic review and meta-analysis of

Ammar W Ashor1, Jose Lara2, John C Mathers2

  • 1Human Nutrition Research Centre, Institute for Ageing and Health, Newcastle University, Campus for Ageing and Vitality, Newcastle on Tyne NE4 5PL, UK; College of Medicine, University of Al-Mustansiriyah, Baghdad, Iraq.

Atherosclerosis
|May 6, 2014
PubMed

Insights

Vitamin C supplementation significantly improves endothelial function (EF), particularly in individuals with cardiovascular disease risk factors. Higher doses showed a greater positive impact on EF, suggesting a beneficial role in cardiovascular health.

Area of Science:

  • Cardiovascular Research
  • Nutritional Science
  • Clinical Trials

Background:

  • Observational studies suggest a link between higher vitamin C intake and reduced cardiovascular disease (CVD) risk.
  • Randomized controlled trials (RCTs) on vitamin C's effect on endothelial function (EF) have yielded inconsistent results.

Purpose of the Study:

  • To systematically review and meta-analyze the effect of vitamin C supplementation on EF.
  • To explore if health status, study duration, dose, or route of administration influence vitamin C's impact on EF.

Main Methods:

  • Searched Medline, Embase, Cochrane Library, and Scopus databases up to May 2013.
  • Included RCTs with adult participants where vitamin C was administered alone.
  • Focused on studies quantifying EF using ultrasound, plethysmography, and pulse wave analysis.

Main Results:

  • Pooled data from 44 trials showed a significant positive effect of vitamin C on EF (SMD: 0.50).
  • Improved EF was observed in patients with atherosclerosis, diabetes, and heart failure.
  • The effect was not influenced by study design, duration, or route of administration, but higher doses correlated with greater EF improvement.

Conclusions:

  • Vitamin C supplementation demonstrably improves endothelial function.
  • The benefits of vitamin C on EF are more pronounced in individuals with higher cardiovascular disease risk.
  • Findings support vitamin C's role in enhancing cardiovascular health, especially in at-risk populations.
Abstract

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.8K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
886
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890